In Vivo bactofection: Listeria can function as a DNA-cancer vaccine

DNA and Cell Biology

Volumn 25, Issue 3, 2006, Pages 142-151

  Souders, N C ^a   Verch, T ^a,b   Paterson, Yvonne ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b FUJIREBIO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; DNA VACCINE; LM LLO E7 VACCINE; PROTEIN E7; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTOFECTION; CANCER GROWTH; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; GENE CONTROL; GENE DELIVERY SYSTEM; GENE VECTOR; GENETIC ENGINEERING; GENETIC TRANSFECTION; GROWTH INHIBITION; IN VIVO STUDY; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; SOLID TUMOR; SUICIDE GENE THERAPY; TUMOR IMMUNITY; UTERINE CERVIX CANCER;

ANIMALS; ANTIGENS, NEOPLASM; BACTERIAL VACCINES; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; DISEASE MODELS, ANIMAL; EPITOPES, T-LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; GENETIC VECTORS; INTERFERON TYPE II; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; PLASMIDS; UTERINE CERVICAL NEOPLASMS; VACCINES, DNA;

LISTERIA; LISTERIA MONOCYTOGENES; MAMMALIA;

EID: 33645502325     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2006.25.142     Document Type: Article

References (32)

1. BOHNE, J., SOKOLOVIC, Z., et al. (1994). Transcriptional regulation of prfA and PrfA-regulated virulence genes in Listeria monocytogenes. Mol. Microbiol. 11, 1141-1150.
2. DECATUR, A.L., and PORTNOY, D.A. (2000). A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity. Science 290, 992-995.
3. DIETRICH, G., BUBERT, A., et al. (1998). Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Nat. Biotechnol. 16: 181-185.
4. DIETRICH, G., GENTSCHEV, I., et al. (1999). Delivery of DNA vaccines by attenuated intracellular bacteria. Immunol. Today 20, 251-253.
5. DIETRICH, G., SPRENG, S., et al. (2003). Live attenuated bacteria as vectors to deliver plasmid DNA vaccines. Curr. Opin. Mol. Ther. 5, 10-19.
6. DOMINIECKI, M.E., BEATTY, G.L., et al. (2005). Tumor sensitivity to IFN-gamma is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors. Cancer Immunol. Immunother. 54, 477-488.
7. DUSSURGET, O., PIZARRO-CERDA, J., et al. (2004). Molecular determinants of Listeria monocytogenes virulence. Annu. Rev. Microbiol. 58, 587-610.
8. FELTKAMP, M.C., SMITS, H.L., et al. (1993). Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol. 23, 2242-2249.
9. GARMORY, H.S., TITBALL, R.W., et al. (2003). Salmonella enterica serovar typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge. Infect. Immun. 71, 3831-3836.
10. GOUSSARD, S., GRILLOT-COURVALIN, C., et al. (2003). Eukaryotic promoters can direct protein synthesis in Gram-negative bacteria. J. Mol. Microbiol. Biotechnol. 6, 211-218.
11. GRILLOT-COURVALIN, C., GOUSSARD, S., et al. (2002). Wild-type intracellular bacteria deliver DNA into mammalian cells. Cell Microbiol. 4, 177-186.
12. GUNN, G.R., ZUBAIR, A., et al. (2001). Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. J. Immunol. 167, 6471-6479.
13. HENSE, M., DOMANN, E. et al. (2001). Eukaryotic expression plasmid transfer from the intracellular bacterium Listeria monocytogenes to host cells. Cell Microbiol. 3, 599-609.
14. HUSSAIN, S.F., and PATERSON, Y. (2005). What is needed for effective antitumor immunotherapy? Lessons learned using Listeria monocytogenes as a live vector for HPV-associated tumors. Cancer Immunol. Immunother. 54, 577-586.
15. LIN, K.Y., GUARNIERI, F.G., et al. (1996). Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56, 21-26.
16. LOEFFLER, J.M., NELSON, D., et al. (2001). Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294, 2170-2172.
17. LOESSNER, M.J., WENDLINGER, G., et al. (1995). Heterogeneous endolysins in Listeria monocytogenes bacteriophages: A new class of enzymes and evidence for conserved holin genes within the siphoviral lysis cassettes. Mol. Microbiol. 16, 1231-1241.
18. MILOHANIC, E., GLASER, P., et al. (2003). Transcriptome analysis of Listeria monocytogenes identifies three groups of genes differently regulated by PrfA. Mol. Microbiol. 47, 1613-1625.
19. PAGLIA, P., MEDINA, E., et al. (1998). Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood 92, 3172-3176.
20. PAN, Z.K., IKONOMIDIS, G., et al. (1995). A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours. Nat. Med. 1, 471-477.
21. PARKIN, D.M., BRAY, F., et al. (2001). Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94, 153-156.
22. PETERS, C., and PATERSON, Y. (2003). Enhancing the immunogenicity of bioengineered Listeria monocytogenes by passaging through live animal hosts. Vaccine 21, 1187-1194.
23. PILGRAM, S., STRITZKER, J., et al. (2003). Bactofection of mammalian cells by Listeria monocytogenes: Improvement and mechanism of DNA delivery. Gene Ther. 10, 2036-2045.
24. SEWELL, D.A., SHAHABI, V., et al. (2004). Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7. Cancer Res. 64, 8821-8825.
25. SHATA, M.T., REITZ, M.S., JR., et al. (2001). Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector. Vaccine 20, 623-629.
26. STRYCH, U., PENLAND, R.L., et al. (2001). Characterization of the alanine racemases from two mycobacteria. FEMS Microbiol. Lett. 196, 93-98.
27. THERIOT, J.A., MITCHISON, T.J., et al. (1992). The rate of actin-based motility of intracellular Listeria monocytogenes equals the rate of actin polymerization. Nature 357, 257-260.
28. THOMPSON, R.J., BOUWER, H.G. et al. (1998). Pathogenicity and immunogenicity of a Listeria monocytogenes strain that requires D-alanine for growth. Infect. Immun. 66, 3552-3561.
29. TILNEY, L.G., and PORTNOY, D.A. (1989). Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes. J. Cell Biol. 109(4 Pt I), 1597-1608.
30. VERCH, T., PAN, Z.K., et al. (2004). Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccines. Infect. Immun. 72, 6418-6425.
31. WILLIAMS, J.R., THAYYULLATHIL, C., et al. (2000). Sequence variations within PrfA DNA binding sites and effects on Listeria monocytogenes virulence gene expression. J. Bacteriol. 182, 837-841.
32. XIANG, R., LODE, H.N., et al. (2000). An autologous oral DNA vaccine protects against murine melanoma. Proc. Natl. Acad. Sci. USA 97, 5492-5497.